Results
|
1581.
|
|
|
1582.
|
|
|
1583.
|
|
|
1584.
|
|
|
1585.
|
|
|
1586.
|
|
|
1587.
|
|
|
1588.
|
|
|
1589.
|
|
|
1590.
|
|
|
1591.
|
|
|
1592.
|
|
|
1593.
|
|
|
1594.
|
|
|
1595.
|
|
|
1596.
|
|
|
1597.
|
|
|
1598.
|
|
|
1599.
|
Bicalutamide ('Casodex') 150 mg in addition to standard care in patients with nonmetastatic prostate cancer: updated results from a randomised double-blind phase III study (median follow-up 5.1 y) in the early prostate cancer programme. [electronic resource] by
- Wirth, M
- Tyrrell, C
- Delaere, K
- Sánchez-Chapado, M
- Ramon, J
- Wallace, D M A
- Hetherington, J
- Pina, F
- Heyns, C
- Borchers, T
- Morris, T
- Armstrong, J
Producer: 20050830
In:
Prostate cancer and prostatic diseases vol. 8
Availability: No items available.
|
|
1600.
|
|